- SRPT has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $19.5 million.
- SRPT traded 119,566 shares today in the pre-market hours as of 8:04 AM, representing 10.4% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in SRPT with the Ticky from Trade-Ideas. See the FREE profile for SRPT NOW at Trade-Ideas More details on SRPT: Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Currently there are 5 analysts that rate Sarepta Therapeutics a buy, no analysts rate it a sell, and 8 rate it a hold. The average volume for Sarepta Therapeutics has been 1.7 million shares per day over the past 30 days. Sarepta has a market cap of $646.1 million and is part of the health care sector and drugs industry. The stock has a beta of 1.68 and a short float of 35.9% with 11.86 days to cover. Shares are down 22.5% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.